Dizal (Jiangsu) Pharmaceutical Co., Ltd. (SHA:688192)
China flag China · Delayed Price · Currency is CNY
58.77
-1.93 (-3.18%)
At close: Jun 5, 2025, 2:57 PM CST

SHA:688192 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2018 - 2019
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2018 - 2019
Operating Revenue
438.22359.991.29-10.29-
Upgrade
Other Revenue
-----27.76
Upgrade
Revenue
438.22359.991.29-10.2927.76
Upgrade
Revenue Growth (YoY)
153.88%294.25%---62.95%-32.32%
Upgrade
Cost of Revenue
16.8611.847.663.6512.9326.56
Upgrade
Gross Profit
421.37348.0683.63-3.65-2.651.2
Upgrade
Selling, General & Admin
627.62598.78437.55128.4487.95340.43
Upgrade
Research & Development
726.72721.16801.15660.87583.67423.94
Upgrade
Other Operating Expenses
1.51-2.1-0.27-0.390.10.49
Upgrade
Operating Expenses
1,3561,3181,239788.9671.73764.84
Upgrade
Operating Income
-934.61-969.66-1,155-792.55-674.37-763.65
Upgrade
Interest Expense
-27-22.75-7.57-4.34-3.07-
Upgrade
Interest & Investment Income
2.182.243.642.533.653.89
Upgrade
Currency Exchange Gain (Loss)
-2.45-2.45-1.4510.1-6.45-28.9
Upgrade
Other Non Operating Income (Expenses)
-0.09-0.07-0.04-0.03-0.08-0.33
Upgrade
EBT Excluding Unusual Items
-961.97-992.69-1,161-784.3-680.32-788.99
Upgrade
Gain (Loss) on Sale of Investments
14.2214.4522.5242.160.970.29
Upgrade
Gain (Loss) on Sale of Assets
---0.010.02-198.82
Upgrade
Other Unusual Items
38.5938.5930.56.399.473.29
Upgrade
Pretax Income
-909.16-939.65-1,108-735.74-669.88-586.58
Upgrade
Income Tax Expense
000.10.26-0.03
Upgrade
Earnings From Continuing Operations
-909.16-939.66-1,108-736-669.88-586.61
Upgrade
Minority Interest in Earnings
94.9393.7----
Upgrade
Net Income
-814.23-845.96-1,108-736-669.88-586.61
Upgrade
Net Income to Common
-814.23-845.96-1,108-736-669.88-586.61
Upgrade
Shares Outstanding (Basic)
415415407404360360
Upgrade
Shares Outstanding (Diluted)
415415407404360360
Upgrade
Shares Change (YoY)
1.45%1.83%0.70%12.29%0.07%-
Upgrade
EPS (Basic)
-1.96-2.04-2.72-1.82-1.86-1.63
Upgrade
EPS (Diluted)
-1.96-2.04-2.72-1.82-1.86-1.63
Upgrade
Free Cash Flow
-852.85-788.1-1,000-677.15-501.26-621.75
Upgrade
Free Cash Flow Per Share
-2.05-1.90-2.46-1.67-1.39-1.73
Upgrade
Gross Margin
96.15%96.71%91.61%--25.72%4.31%
Upgrade
Operating Margin
-213.27%-269.43%-1265.43%--6556.55%-2750.82%
Upgrade
Profit Margin
-185.80%-235.05%-1213.42%--6512.85%-2113.09%
Upgrade
Free Cash Flow Margin
-194.62%-218.98%-1095.44%--4873.51%-2239.65%
Upgrade
EBITDA
-895.37-930.08-1,114-753.85-636.97-733.83
Upgrade
EBITDA Margin
-204.32%-258.43%----
Upgrade
D&A For EBITDA
39.2439.5840.9438.737.429.82
Upgrade
EBIT
-934.61-969.66-1,155-792.55-674.37-763.65
Upgrade
EBIT Margin
-213.27%-269.43%----
Upgrade
Revenue as Reported
438.22359.991.29-10.2927.76
Upgrade
Advertising Expenses
---1.94--
Upgrade
Updated Feb 24, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.